Is ATNM or AVBP more undervalued in 2026?

CirclFi compares Actinium Pharmaceuticals, Inc. (ATNM) and ArriVent BioPharma, Inc. (AVBP) using 13 institutional-grade valuation models. ATNM has a Quality of Company score of 5.3/10 while AVBP scores 3.6/10.

Which is a better buy — ATNM or AVBP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ATNM and AVBP valuations compare?

ATNM at $1.26 and AVBP at $30.27 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ATNM vs AVBP Valuation Comparison 2026 — Intrinsic Value Analysis

ATNM

Pharmaceutical Preparations

Actinium Pharmaceuticals, Inc.

Quality

5.3

out of 10

Value Trap

LOW

Price

$1.26

Last close

Models

9/13

Active

AVBP

Pharmaceutical Preparations

ArriVent BioPharma, Inc.

Quality

3.6

out of 10

Value Trap

SAFE

Price

$30.27

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ATNM Fair Value	ATNM Upside	AVBP Fair Value	AVBP Upside
Bayesian DCF	Intrinsic	$0.96	-23.8%	$7.91	-73.9%
First Chicago	Scenario	$0.63	-49.6%	$59.62	+120.8%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.83	+45.2%	$6.38	-78.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ATNM vs AVBP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ATNM vs AVBP — Which Stock Is More Undervalued?

ATNM scores higher with a 5.3/10 quality rating vs AVBP's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Actinium Pharmaceuticals, Inc. (ATNM) and ArriVent BioPharma, Inc. (AVBP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ATNM currently trades at $1.26 with a QOC of 5.3/10, while AVBP trades at $30.27 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).